Orexo strengthens its sustainability work by establishing a social financing framework

Proceeds from any Social Financing Instruments are fully dedicated to the financing of projects with a positive social impact and expected to help advance the following SDG and targets, as further described in the Social Framework: Proceeds from any Social Financing Instruments are fully dedicated to the financing of projects with a positive social impact and expected to help advance the following SDG and targets, as further described in the Social Framework: Morningstar Sustainalytics has...

Proceeds from any Social Financing Instruments are fully dedicated to the financing of projects with a positive social impact and expected to help advance the following SDG and targets, as further described in the Social Framework:

Morningstar Sustainalytics has conducted an independent review of the Social Framework and concludes it to be aligned with ICMA's (International Capital Market Association) Social Bond Principles 2023 and the APLMA (Asia Pacific Loan Market Association)/LMA (Loan Market Association)/LSTA's (Loan Syndications and Trading Association) Social Loan Principles 2023 (the 'Second Opinion'). Additionally, Sustainalytics considers the Social Framework to be credible, impactful and to be aligned with the overall sustainability strategy of the Company and that the use of proceeds category will contribute to the advancement of UN Sustainable Development Goal 3 – Good Health and Wellbeing.

The Social Framework and the Second Opinion are available on Orexos's website under the heading ESG Sustainable investing and Orexo intends to regularly report on the underlying social eligible projects which will be published on the Company's website.

ABG Sundal Collier AB and Carnegie Investment Bank have acted structuring advisors in connection to the establishment of the Social Framework.

As announced today in a separate press release, Orexo contemplates to issue new senior secured callable floating rate social bonds under the Social Framework.

For further information please contact:
Nikolaj Sørensen, President and CEO
Fredrik Järrsten, EVP and CFO
Lena Wange, IR & Communications Director

Tel: +46 (0)18 780 88 00
E-mail: ir@orexo.com  

About Orexo
Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million, and the number of employees to 116. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.

For more information about Orexo please visit www.orexo.com.  You can also follow Orexo on X, LinkedIn, and YouTube.

Morningstar Sustainalytics, a globally-recognized provider of ESG research, ratings and data, evaluated Orexo's Framework and the alignment thereof with relevant industry standards and provided views on the robustness and credibility of the Framework. In no event shall the Social Financing Framework nor any portion thereof be construed as part of the offering, nor shall be considered as an offer or advertisement to buy a security, solicitation of votes or proxies, investment advice, expert opinion or negative assurance letter as defined by the applicable legislation.

The information was sent for publication, through the agency of the contact person set out above, on March 8, 2024, at 8 CET.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/orexo/r/orexo-strengthens-its-sustainability-work-by-establishing-a-social-financing-framework,c3942836

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/orexo-strengthens-its-sustainability-work-by-establishing-a-social-financing-framework-302083869.html